Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Analysis of the Global Oral Solid Dosage Excipients Market, Forecast to 2025

Analysis of the Global Oral Solid Dosage Excipients Market, Forecast to 2025

Flexible Oral Solid Dosage Forms Along with Patient-compliant Formulations will Drive Market Growth

RELEASE DATE
09-Jun-2020
REGION
Global
Research Code: K462-01-00-00-00
SKU: CM01787-GL-MR_24464
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
CM01787-GL-MR_24464

$4,950.00

$3,712.50save 25 %

DownloadLink
Add to Compare
ENQUIRE NOW

Description

Excipients have been a part of the pharmaceutical industry and their demand is expected to increase during the forecast period. This is owing to their ability to perform various functions such as improving the stability of the active pharmaceutical ingredient (API), modifying drug release, and masking taste. Expanding patient base coupled with the need to develop cost-effective drugs has led to the growth of generics. This has simultaneously driven the need of excipients that can be successfully utilized for these drugs. Excipients impart no medicinal properties to the drug; they have well-defined roles ranging from protecting the API to easing the manufacturing process. Factors such as patent expiration of blockbuster drugs, which will consequently boost the demand for generic drugs, and increasing demand for patient-compliant drugs have boosted the demand for oral solid dosage excipients. However, a stringent regulatory process is one of the roadblocks to the development of novel excipients. Long development timelines, high investment into R&D, and chances of failure have prevented manufacturers from developing novel excipients. For instance, antioxidants such as ascorbic acid are used in combination with compounds that are prone to oxidation, hence improving the efficiency of the formulation.

Areas of Growth:
Continuous manufacturing technology has gained prominence in the solid drug manufacturing arena. Although traditional processes are still incorporated in the continuous process line, the requirement of ingredients has differed. Therefore, there is a need for excipients that are well suited for the continuous process. The rise in the geriatric, children and mentally-disabled population has increased the demand for flexible oral dosage formulations including chewable tablets and lozenges. With the influx of such flexible oral solid dosage formations, the demand for excipients compatible with them has subsequently increased.

Regional Analysis:
North America has dominated the market and is expected to sustain this position during the forecast period. Strong economic growth increases the affordability quotient, which results in an increased demand for better healthcare services in the region. Asia-Pacific (APAC), on the other hand, is expected to witness the highest growth during the period of this study.

Competitive Structure:
In terms of market participation, Tier 1 companies including BASF, Ashland, Evonik, and Roquette occupied a share of around 45%-55% thus dominating the market. Tier 2 companies held a share of 25%-35%, followed by Tier 3 companies with a share of 10%-15%. Moreover, Tier 1 and Tier 2 companies have adopted strategies like partnerships and acquisitions to expand their customer base and establish a global presence.

Table of Contents

Executive Summary—Strategic Factsheet

Market Engineering Measurements

CEO’s Perspective

Market Definitions

Market Segmentation

Geographic Scope

Key Questions this Study will Answer

Percent Revenue Forecast by Region

Market Segmentation Description

Excipients and Compendia Monograph

Good Manufacturing Practice (GMP) Guide Timeline

The Need for Certification

Market Drivers

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Market Restraints

Restraints Explained

Restraints Explained (continued)

Market Engineering Measurements

Forecast Assumptions

Revenue Forecast

Revenue Forecast Discussion

Percent Revenue Forecast by Region

Revenue Forecast by Region

Revenue Breakdown by Region

Revenue Forecast Discussion by Region

Revenue Forecast Discussion by Region (continued)

Percent Revenue Forecast by Functionality

Revenue Forecast by Functionality

Revenue Forecast Discussion by Functionality

Binders & Fillers Segment—Percent Revenue by Product Type

Binders & Fillers Segment—Percent Revenue Discussion by Product Type

Coatings Segment—Percent Revenue by Product Type

Coatings Segment—Percent Revenue Discussion by Product Type

Disintegrants Segment—Percent Revenue by Product Type

Others Segment—Percent Revenue by Product Type

Others Segment—Percent Revenue Discussion by Product Type

Total Oral Solid Dosage Excipients Market Value Chain

Value Chain Description

Oral Solid Dosage Excipients Market—Competitive Landscape

Competitive Environment

Market Share Analysis—Market Participant Activities

Market Share Analysis—Market Participant Activities (continued)

Growth Opportunity 1—Increasing Demand for Solubility-enhancing Excipients

Growth Opportunity 2—Need for an Exclusive Excipient Approval Regulatory Agency

Strategic Imperatives for Success and Growth

Market Trends

Increasing Demand for New Excipients

Examples of New Excipients

Examples of New Excipients (continued)

Types of New Excipients 1—Novel Excipients

Types of New Excipients 2—Modified Excipients

Types of New Excipients 3—Co-processed Excipients

Examples of Co-processed Excipients

CDMO & Outsourcing

Modified Dosage Forms

Flexible Oral Solid Dosage Forms

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Percent Revenue Forecast by Functionality

Revenue Forecast by Functionality

Revenue Forecast Discussion by Functionality

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Percent Revenue Forecast by Functionality

Revenue Forecast by Functionality

Revenue Forecast Discussion by Functionality

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Percent Revenue Forecast by Functionality

Revenue Forecast by Functionality

Revenue Forecast Discussion by Functionality

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Percent Revenue Forecast by Functionality

Revenue Forecast by Functionality

Revenue Forecast Discussion by Functionality

The Last Word—3 Big Predictions

Legal Disclaimer

Market Engineering Methodology

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)

Request Sample
Popular Topics

3d printer market share

residential solar market

consumer electronics market

packaged food industry

diabetes devices market

neurology market

photovoltaic market

bioinformatics market

agricultural drones market

natural gas market

Excipients have been a part of the pharmaceutical industry and their demand is expected to increase during the forecast period. This is owing to their ability to perform various functions such as improving the stability of the active pharmaceutical ingredient (API), modifying drug release, and masking taste. Expanding patient base coupled with the need to develop cost-effective drugs has led to the growth of generics. This has simultaneously driven the need of excipients that can be successfully utilized for these drugs. Excipients impart no medicinal properties to the drug; they have well-defined roles ranging from protecting the API to easing the manufacturing process. Factors such as patent expiration of blockbuster drugs, which will consequently boost the demand for generic drugs, and increasing demand for patient-compliant drugs have boosted the demand for oral solid dosage excipients. However, a stringent regulatory process is one of the roadblocks to the development of novel excipients. Long development timelines, high investment into R&D, and chances of failure have prevented manufacturers from developing novel excipients. For instance, antioxidants such as ascorbic acid are used in combination with compounds that are prone to oxidation, hence improving the efficiency of the formulation. Areas of Growth: Continuous manufacturing technology has gained prominence in the solid drug manufacturing arena. Although traditional processes are still incorporated in the continuous process line, the requirement of ingredients has differed. Therefore, there is a need for excipients that are well suited for the continuous process. The rise in the geriatric, children and mentally-disabled population has increased the demand for flexible oral dosage formulations including chewable tablets and lozenges. With the influx of such flexible oral solid dosage formations, the demand for excipients compatible with them has subsequently increased. Regional Analysis: North America has dominated the market and is expected to sustain this position during the forecast period. Strong economic growth increases the affordability quotient, which results in an increased demand for better healthcare services in the region. Asia-Pacific (APAC), on the other hand, is expected to witness the highest growth during the period of this study. Competitive Structure: In terms of market participation, Tier 1 companies including BASF, Ashland, Evonik, and Roquette occupied a share of around 45%-55% thus dominating the market. Tier 2 companies held a share of 25%-35%, followed by Tier 3 companies with a share of 10%-15%. Moreover, Tier 1 and Tier 2 companies have adopted strategies like partnerships and acquisitions to expand their customer base and establish a global presence.
More Information
No Index No
Podcast No
Author Prateeksha Kaul
Industries Chemicals and Materials
WIP Number K462-01-00-00-00
Is Prebook No
GPS Codes 9100-A2,9938-A2,9595